158663-49-1

Basic information

• Product Name: N*1*-(2-Methoxy-benzyl)-N*1*-Methyl-ethane-1,2-diaMine
• Synonyms: N*1*-(2-Methoxy-benzyl)-N*1*-Methyl-ethane-1,2-diaMine;N'-[(2-methoxyphenyl)methyl]-N'-methylethane-1,2-diamine
• CAS NO: 158663-49-1
• Molecular Formula: C11H18N2O
• Molecular Weight: 194.27342
• Mol File: 158663-49-1.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: N*1*-(2-Methoxy-benzyl)-N*1*-Methyl-ethane-1,2-diaMine(CAS DataBase Reference)
• NIST Chemistry Reference: N*1*-(2-Methoxy-benzyl)-N*1*-Methyl-ethane-1,2-diaMine(158663-49-1)
• EPA Substance Registry System: N*1*-(2-Methoxy-benzyl)-N*1*-Methyl-ethane-1,2-diaMine(158663-49-1)

Safety Data

• Hazardous Substances Data: 158663-49-1(Hazardous Substances Data)

Upstream product

• 6851-80-5 2-methoxy-N-methylbenzylamine 

Relevant articles and documents

Design, synthesis and evaluation of scutellarein-O-acetamidoalkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer's disease

A series of scutellarein-O-acetamidoalkylbenzylamines derivatives were designed based on a multitarget-directed ligands strategy for the treatment of Alzheimer's disease. Among these compounds, compound T-22 demonstrated excellent acetylcholinesterase inhibitory, moderate inhibitory effects on self-induced Aβ1-42 aggregation, Cu2+-induced Aβ1-42 aggregation, human AChE-induced Aβ1-40 aggregation and disassembled Cu2+-induced aggregation of the well-structured Aβ1-42 fibrils, and also acted as potential antioxidant and biometals chelator. Both kinetic analysis of AChE inhibition and molecular modeling study suggested that T-22 interacted with both the catalytic active site and peripheral anionic site of AChE. Moreover, compound T-22 showed a good neuroprotective effect against H2O2-induced PC12?cell injury and low toxicity in SH-SY5Y cells. Furthermore, the step-down passive avoidance test indicated T-22 significantly reversed scopolamine-induced memory deficit in mice. Taken together, the data showed that T-22 was an interesting multifunctional lead compound worthy of further study for AD.

N-acylpiperidine tachykinin antagonists

N-Acylpiperidines of general structure STR1 are tachykinin receptor antagonists useful in the treatment of inflammatory diseases, pain or migraine, asthma and emesis.